NO930844L - 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater - Google Patents

2-(2-substituerte pyrrolidinyltio)karbapenem-derivater

Info

Publication number
NO930844L
NO930844L NO93930844A NO930844A NO930844L NO 930844 L NO930844 L NO 930844L NO 93930844 A NO93930844 A NO 93930844A NO 930844 A NO930844 A NO 930844A NO 930844 L NO930844 L NO 930844L
Authority
NO
Norway
Prior art keywords
group
atom
hydrogen atom
substituents
nitrogen atom
Prior art date
Application number
NO93930844A
Other languages
English (en)
Other versions
NO930844D0 (no
Inventor
Susumu Nakagawa
Norikazu Ohtake
Shigemitsu Okada
Ryosuke Ushijima
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of NO930844D0 publication Critical patent/NO930844D0/no
Publication of NO930844L publication Critical patent/NO930844L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Forbindelse med formelen (I): hvor R1 er et hydrogenatom eller en metylgruppe. R2 er et hydrogenatom eller en negativ ladning, R3 er et hydrogenatom eller en lavere alkylgruppe, R', R5 og R6 er et hydrogenatom, en cyanogruppe, en metansulfonylgruppe, en lavere alkylgruppe som kan ha substituenter, en karbamoylgruppe som kan ha substituenter eller en gruppe med formelen -X-N(R7)R8 {hvor R7 og R8 som kan være de samme eller forskjellige, er et hydro- genatom eller en lavere alkylgruppe som kan ha substituenter, eller R7 og R8, sammen med det tilstøtende nitrogenatom og, om nødvendig, sammen med et heteroatom valgt fra gruppen bestå- ende av et nitrogenatom, et oksygenatom og et svovelatom i tillegg til det tilstøtende nitrogenatom, danner en 3- til 8- leddet heterocyklisk gruppe som kan være substituert (forut- satt at enten nitrogenatomet tilstøtende X eller et annet nitrogenatom på den heterocykliske ring, kan danne en ammonio- gruppe), og X er en lavere alkylengruppe som kan ha substitu- enter}, forutsatt at minst en av R', R5 og R6 er gruppen med formelen -X-N(R7)R8, hvor R7, R8 og X er som definert ovenfor, og Y er en lavere alkylengruppe eller en enkeltbinding; eller et farmasøytisk akseptabelt salt eller ester derav.
NO93930844A 1991-07-09 1993-03-08 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater NO930844L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19476791 1991-07-09
JP34959191 1991-12-07
PCT/JP1992/000864 WO1993001192A1 (en) 1991-07-09 1992-07-07 2-(2-substituted pyrrolidinylthio)carbapenem derivatives

Publications (2)

Publication Number Publication Date
NO930844D0 NO930844D0 (no) 1993-03-08
NO930844L true NO930844L (no) 1993-05-07

Family

ID=26508721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930844A NO930844L (no) 1991-07-09 1993-03-08 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater

Country Status (12)

Country Link
EP (1) EP0522504A1 (no)
KR (1) KR930702353A (no)
AU (1) AU646577B2 (no)
CA (1) CA2073377A1 (no)
CZ (1) CZ214492A3 (no)
FI (1) FI931015A (no)
IE (1) IE922225A1 (no)
IL (1) IL102453A (no)
NO (1) NO930844L (no)
TW (1) TW206226B (no)
WO (1) WO1993001192A1 (no)
YU (1) YU68292A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216102D0 (en) * 1992-07-29 1992-09-09 Smithkline Beecham Plc Pharmaceutical substances
KR950014111A (ko) * 1993-11-23 1995-06-15 유충식 새로운 카바페넴 유도체 및 그 제조방법
KR970010769A (ko) * 1995-08-01 1997-03-27 유충식 카바페넴 유도체의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
AU631671B2 (en) * 1989-08-04 1992-12-03 Banyu Pharmaceutical Co., Ltd. 2-(2-vinylpyrrolidinylthio)carbapenem derivatives

Also Published As

Publication number Publication date
FI931015A0 (fi) 1993-03-08
NO930844D0 (no) 1993-03-08
AU1947192A (en) 1993-01-14
WO1993001192A1 (en) 1993-01-21
TW206226B (no) 1993-05-21
CZ214492A3 (en) 1993-01-13
CA2073377A1 (en) 1993-01-10
EP0522504A1 (en) 1993-01-13
YU68292A (sh) 1995-03-27
IL102453A (en) 1996-01-19
FI931015A (fi) 1993-03-08
IE922225A1 (en) 1993-01-13
AU646577B2 (en) 1994-02-24
KR930702353A (ko) 1993-09-08
IL102453A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
ES453376A1 (es) Un procedimiento para la preparacion de una composicion her-bicida a partir de derivados de pirazol.
AU556150B2 (en) Dihydropyridine derivatives
ES8401959A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
IE780853L (en) Aminoalkyl thiophene derivatives
NO159794C (no) Analogifremgangsm te ved fremstilling av terapeutisk virksomme 7-substituerte theofyllinderivater.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
NO930844L (no) 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater
DE3869163D1 (de) Benzylidenamino-, benzylamino- und benzoylamino-imidazolderivate.
FI915026A0 (fi) 2-(substituerad pyrrolidinyltio) carbapenem derivat.
ES483116A1 (es) Procedimiento para la preparacion de derivados de acidos aziridin-2-carboxilicos substituidos en n, inmunoestimulan- tes
DE68911006D1 (de) Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung.
ATE58902T1 (de) Penem-derivate.
IE45200L (en) Pharmaceutical composition
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
ES8607940A1 (es) Procedimiento de preparacion de nuevos derivados de la 8-carbamoilaminoisoquinolina y de sus sales de adicion acida
NO914640L (no) 2-(substituert pyrrolidinyltio) karbapenemderivater
ES474282A1 (es) Un procedimiento para producir un compuesto de piridazinoma.
JPS5430166A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5430169A (en) 2-aminoalkyl-5-phenyloxazoles and their pharmaceutically acceptable aicd salts
JPS5430168A (en) 2-(2-aminoethyl)-5-phenyloxazoles and their pharmaceutically acceptable acid salts